DeCode Debate
This article was originally published in Start Up
Executive Summary
In Iceland, public debate has broken out about deCode Genetics' commercial rights to a database of medical information about the country's population. Will Roche, which in 1998 signed a $200+ million agreement with deCode to pursue genetic leads into cardiovascular neurological and metabolic diseases, get all it bargained for?